Therapeutic effect and side effects of Bevacizumab combined with Irinotecan in the treatment of paediatric intracranial tumours: Meta‐analysis and Systematic Review

WHAT IS KNOWN AND OBJECTIVE: Bevacizumab (BVZ) is an angiogenesis inhibitor that often works well with chemotherapeutic drugs for the treatment of solid intracranial tumours in children. This meta‐analysis discusses the efficacy and side effects of BVZ combined with irinotecan in the treatment of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yan, Li, Qiang, Ma, Hai‐Yang, Sun, Tao, Xiang, Ruo‐Lan, Di, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689821/
https://www.ncbi.nlm.nih.gov/pubmed/32598559
http://dx.doi.org/10.1111/jcpt.13228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689821/
https://www.ncbi.nlm.nih.gov/pubmed/32598559
http://dx.doi.org/10.1111/jcpt.13228

Ejemplares similares